Puberty blockers for people aged under 18 with gender dysphoria will be indefinitely banned by the UK Government.
Emerging infectious diseases necessitate rapid production of raw materials for vaccines. Strengthening domestic production and a resilient supply chain are key; advanced manufacturing facilities, like ...
China’s NMPA has granted approval to Santhera Pharmaceuticals’ AGAMREE, used in treating DMD in individuals aged four years and above.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback